Vysis Announces That Habschmidt Is New CFO | GenomeWeb

DOWNERS GROVE, Ill.--Vysis, a genomic diagnostics company here, has named James Habschmidt as its chief financial officer. Habschmidt was formerly executive vice-president of business development and finance and chief financial officer of Rand McNally.

Among its other products, Vysis offers a line of genetic imaging workstations. Habschmidt "will play an active role in corporate developments as Vysis continues to expand its market presence," predicted John Bishop, Vysis's president and CEO.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.